Xuefei Liu

8PUBLICATIONS
74CO-AUTHORS
Molecular targetsPredictive and prognostic markersBiomaterialsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 23, 2026
The PDGFB-DDX5 axis contributes to breast cancer radioresistance through HR-associated DNA repair.

|Apr 24, 2026
NMB+CXCL13+CD4+ T Cell-Derived Neuromedin B Promotes Neuropeptide S Receptor 1-Positive Malignant Cell Senescence and Malignancy.

|Apr 13, 2026
GPNMB Drives Brain Metastasis by Sculpting a Pathologic Endothelial-Immune Interactome.

Xuefei Liu, Jun Tan, Chun Wu

|Jan 20, 2026
PRDM1+ Malignant Cells Mediate an Immunosuppressive Landscape and Resistance to Neoadjuvant Chemoradiotherapy and Immunotherapy in Esophageal Squamous Cell Carcinoma.

Dijian Shen, Rui Li, Yong She

|Dec 19, 2025
Cortactin Suppresses mTOR-Dependent Senescence in Circulating Tumor Cells.

Jianyang Hu, Binyu Zhang, Junhao Chen

|Dec 04, 2025
Fusion of Tumor Cells with Lipid-Associated Macrophages Drives Metastatic Progression of Breast Cancer.

Yixin Cheng, Guanyin Huang, Xuefei Liu

Pageof 2

Frequent Collaborators

5 joint publications

Xin Hong

4 joint publications

Yixin Cheng

4 joint publications

Guanyin Huang

4 joint publications

Chun Wu